FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116098261> ?p ?o ?g. }

• W2116098261 endingPage "31" @default.
• W2116098261 startingPage "2426" @default.
• W2116098261 abstract "The effect of culture conditions on the glutamylation of methotrexate by intact H35 hepatoma cells and folylpolyglutamate synthetase (FPGS) activity in the corresponding crude extracts has been examined. The rate of cellular glutamylation of methotrexate observed in rapidly dividing cultures was 4-fold higher than confluent cultures, and was accompanied by an increase in extract FPGS activity (2.2-fold). The depletion of cellular folates produced comparable increases in both cellular methotrexate glutamylation and extract FPGS activity (approximately 1.8-fold). Near-quantitative reductions in cellular methotrexate glutamylation were caused by media additions of reduced folates and methotrexate to confluent cultures of wild-type and folate-depleted H35 cells. However, these produced relatively modest reductions in FPGS activity in the corresponding crude extracts (approximately 50%). Methionine exclusion resulted in a greater than 50% decrease in FPGS activity in crude extracts of these cells compared to extracts of control cultures. The combination of methionine exclusion and folinic acid addition lowered the FPGS activity to less than 25% that of control. The data suggest that the changes in the glutamylation rate of methotrexate in whole cells due to culture conditions such as folate restriction, reduced folate addition, methionine exclusion, and growth state are at least in part a consequence of alterations in FPGS activity. This conclusion is consistent with the proposition that the metabolism of slow-acting substrates for FPGS (such as 4-amino antifolates and their corresponding polyglutamates) may be sensitive to changes in enzyme levels or activity (Cook et al., Biochemistry, 26: 530-539, 1987). Analysis of the products formed by FPGS from extracts using methotrexate as the substrate revealed no significant amounts of polyglutamate species higher than 4-NH2-10-CH3-PteGlu3. In contrast, when using the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid as the starting substrate under identical assay conditions, FPGS from extracts catalyzed the formation of predominantly long chain polyglutamate derivatives (Glu4 and higher). These results reflect the relative efficacy of methotrexate and N10-propargyl-5,8-dideazafolic acid, as well as their polyglutamate derivatives, as substrates for FPGS." @default.
• W2116098261 created "2016-06-24" @default.
• W2116098261 creator A5007959133 @default.
• W2116098261 creator A5016194536 @default.
• W2116098261 creator A5062563049 @default.
• W2116098261 date "1988-05-01" @default.
• W2116098261 modified "2023-09-24" @default.
• W2116098261 title "Role of folylpolyglutamate synthetase in the regulation of methotrexate polyglutamate formation in H35 hepatoma cells." @default.
• W2116098261 cites W1487023742 @default.
• W2116098261 cites W1536608791 @default.
• W2116098261 cites W1540897124 @default.
• W2116098261 cites W1552992005 @default.
• W2116098261 cites W1569324528 @default.
• W2116098261 cites W1589281120 @default.
• W2116098261 cites W1634390593 @default.
• W2116098261 cites W1649636917 @default.
• W2116098261 cites W1775749144 @default.
• W2116098261 cites W1778909962 @default.
• W2116098261 cites W1967594567 @default.
• W2116098261 cites W1983449164 @default.
• W2116098261 cites W2001515975 @default.
• W2116098261 cites W2003098361 @default.
• W2116098261 cites W2005962086 @default.
• W2116098261 cites W2010880776 @default.
• W2116098261 cites W2018799134 @default.
• W2116098261 cites W2025654172 @default.
• W2116098261 cites W2029582047 @default.
• W2116098261 cites W2041719461 @default.
• W2116098261 cites W2055588186 @default.
• W2116098261 cites W2062948593 @default.
• W2116098261 cites W2076608291 @default.
• W2116098261 cites W2082898221 @default.
• W2116098261 cites W2107241699 @default.
• W2116098261 cites W2135045386 @default.
• W2116098261 cites W2154975873 @default.
• W2116098261 cites W2204197747 @default.
• W2116098261 cites W2401696156 @default.
• W2116098261 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2451560" @default.
• W2116098261 hasPublicationYear "1988" @default.
• W2116098261 type Work @default.
• W2116098261 sameAs 2116098261 @default.
• W2116098261 citedByCount "10" @default.
• W2116098261 countsByYear W21160982612017 @default.
• W2116098261 crossrefType "journal-article" @default.
• W2116098261 hasAuthorship W2116098261A5007959133 @default.
• W2116098261 hasAuthorship W2116098261A5016194536 @default.
• W2116098261 hasAuthorship W2116098261A5062563049 @default.
• W2116098261 hasConcept C121608353 @default.
• W2116098261 hasConcept C181199279 @default.
• W2116098261 hasConcept C185592680 @default.
• W2116098261 hasConcept C203014093 @default.
• W2116098261 hasConcept C2776694085 @default.
• W2116098261 hasConcept C2778397455 @default.
• W2116098261 hasConcept C2779804826 @default.
• W2116098261 hasConcept C2780306303 @default.
• W2116098261 hasConcept C2780456651 @default.
• W2116098261 hasConcept C2780912031 @default.
• W2116098261 hasConcept C2781059491 @default.
• W2116098261 hasConcept C2781382166 @default.
• W2116098261 hasConcept C515207424 @default.
• W2116098261 hasConcept C54355233 @default.
• W2116098261 hasConcept C55493867 @default.
• W2116098261 hasConcept C81885089 @default.
• W2116098261 hasConcept C86803240 @default.
• W2116098261 hasConcept C96232424 @default.
• W2116098261 hasConceptScore W2116098261C121608353 @default.
• W2116098261 hasConceptScore W2116098261C181199279 @default.
• W2116098261 hasConceptScore W2116098261C185592680 @default.
• W2116098261 hasConceptScore W2116098261C203014093 @default.
• W2116098261 hasConceptScore W2116098261C2776694085 @default.
• W2116098261 hasConceptScore W2116098261C2778397455 @default.
• W2116098261 hasConceptScore W2116098261C2779804826 @default.
• W2116098261 hasConceptScore W2116098261C2780306303 @default.
• W2116098261 hasConceptScore W2116098261C2780456651 @default.
• W2116098261 hasConceptScore W2116098261C2780912031 @default.
• W2116098261 hasConceptScore W2116098261C2781059491 @default.
• W2116098261 hasConceptScore W2116098261C2781382166 @default.
• W2116098261 hasConceptScore W2116098261C515207424 @default.
• W2116098261 hasConceptScore W2116098261C54355233 @default.
• W2116098261 hasConceptScore W2116098261C55493867 @default.
• W2116098261 hasConceptScore W2116098261C81885089 @default.
• W2116098261 hasConceptScore W2116098261C86803240 @default.
• W2116098261 hasConceptScore W2116098261C96232424 @default.
• W2116098261 hasIssue "9" @default.
• W2116098261 hasLocation W21160982611 @default.
• W2116098261 hasOpenAccess W2116098261 @default.
• W2116098261 hasPrimaryLocation W21160982611 @default.
• W2116098261 hasRelatedWork W1487023742 @default.
• W2116098261 hasRelatedWork W1980257239 @default.
• W2116098261 hasRelatedWork W2010981833 @default.
• W2116098261 hasRelatedWork W2020618832 @default.
• W2116098261 hasRelatedWork W2029252545 @default.
• W2116098261 hasRelatedWork W2068695759 @default.
• W2116098261 hasRelatedWork W2072914052 @default.
• W2116098261 hasRelatedWork W2292366729 @default.
• W2116098261 hasRelatedWork W2408950686 @default.
• W2116098261 hasRelatedWork W2772685935 @default.
• W2116098261 hasVolume "48" @default.

• next